Expectations trend
FY2028 · fiscal year ending 2028-09-27 · fmp
Blue Bird Corp. (BLBD)
NASDAQIndustrialsAuto - ManufacturersSnapshot 2026-11-04
$59.19-2.95%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsAuto - ManufacturersSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.61 → 5.50 EPS · FY ending Sep 27, 2028 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BLBD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Free cash flow improves next quarter | Free cash flow is expected to improve. | Improving | Free cash flow falls or stays negative next quarter | Free cash flow: $21.661M FY2026-Q3; GAAP. Published target: positive or improving. The target does not explicitly identify fiscal versus calendar quarters. Aug 5, 202621,661,000 USD · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-27 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is an execution-led industrial growth story, with recent financial performance strong and the signal now favorable. The long-term thesis is intact, but management has been volatile and alternative-powered bus delivery progress is mixed.
BLBD is described as cheap versus peers, and the pricing setup is considered justified rather than fragile. The expectations gap is negative, which suggests expectations are below the evidence snapshot’s central case, though valuation confidence is only medium.
Near term, revenue growth and raised 2026 guidance support the business trajectory: revenue rose from $333 million in Q1 to $517 million in Q3, while adjusted EBITDA guidance increased to $247 million. Execution risk remains, including a 24% estimated miss probability and the possibility of a credibility hit if guidance is cut after being raised; the sector backdrop is also a headwind.
Over the next few quarters, the key test is whether BLBD delivers on its raised 2026 guidance without reversing course. Alternative-powered bus leadership also depends on turning deliveries and firm electric-bus backlogs into continued progress. XOS earnings and guidance are a sector signal: continued strength could support the industrial backdrop, while misses or lower guidance could weaken it.
For a 1 to 3 year view, BLBD combines strong recent execution and peer-relative cheapness with moderate risk, volatile management, and a headwind from the sector. The thesis remains intact, but it depends on guidance delivery and continued progress in alternative-powered buses. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Profit margin should be at least 15%. |
| Intact |
| Gross margin falls below 15% next quarter |
Gross margin: 19.99% FY2026-Q3; GAAP. Published target: >=15 PERCENT. Target percentage unit is not explicit. Aug 5, 202619.988785 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Management delivers on growth and margin targets | A supporting condition in Blue Bird Corp.'s published investment case. The stated target is consistent progress toward $2.5B revenue and 15% margin. | Improving | Management fails to make steady progress on targets | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue of at least $1.75 billion next quarter | Blue Bird aims for $1.75 billion revenue next quarter. | Intact | Revenue falls below $1.45 billion next quarter | Revenue: $517.16M FY2026-Q3; GAAP. Published target: >=1750 USD_MILLIONS. The target does not explicitly identify fiscal versus calendar quarters. Aug 5, 2026517,160,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$5.58 → $5.50 · observed estimates
$2.22B → $2.24B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-28 | $5.58 | $2,217,084,800 | 2 / 2 |
| 2026-09-29 | $5.58 | $2,217,084,800 | 2 / 2 |
| 2026-09-30 | $5.58 | $2,217,084,800 | 2 / 2 |
| 2026-10-01 | $5.58 | $2,217,084,800 | 2 / 2 |
| 2026-10-02 | $5.61 | $2,241,638,600 | 2 / 2 |
| 2026-10-03 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-04 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-05 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-06 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-07 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-08 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-09 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-10 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-11 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-12 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-13 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-14 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-15 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-16 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-17 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-18 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-19 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-20 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-21 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-22 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-23 | $5.61 | $2,241,638,600 | 3 / 3 |
| 2026-10-24 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-25 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-26 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-27 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-28 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-29 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-30 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-10-31 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-11-01 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-11-02 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-11-03 | $5.50 | $2,241,638,600 | 3 / 3 |
| 2026-11-04 | $5.50 | $2,241,638,600 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 8 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 23, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.